Deprecated: Function WP_Dependencies->add_data() was called with an argument that is deprecated since version 6.9.0! IE conditional comments are ignored by all supported browsers. in /home/gt7hypi/public_html/wp-includes/functions.php on line 6170

Weightloss. Appetite-control. Metabolism.

Zepbound in Pasadena CA

Bound for Change. Bound for Results.

Call now

What is Zepbound?

Zepbound is a prescription medication used for weight loss, appetite control, and metabolism regulation. It contains tirzepatide, a dual GIP and GLP-1 receptor agonist, which helps reduce food intake, improve insulin sensitivity, and support sustained weight reduction in adults with obesity or overweight conditions.

Conditions treated

01

Obesity

For adults with a BMI ≥30

02

Overweight with comorbidities

For adults with a BMI ≥27 and weight-related conditions

03

Appetite dysregulation

Helps control hunger and reduce food intake.

How does it work?

Zepbound works by activating GIP and GLP-1 receptors to regulate appetite, insulin, and metabolism. Its active ingredient, tirzepatide, mimics gut hormones that:

  • Increase insulin when blood sugar is high

  • Lower glucagon to reduce glucose production

  • Slow stomach emptying to prolong fullness

  • Reduce appetite to decrease calorie intake

Key Benefits of Zepbound

  • Significant weight loss – Up to 22.5% body weight reduction in trials

  • Appetite control – Reduces hunger and cravings

  • Improved insulin sensitivity – Supports better glucose metabolism

  • Once-weekly dosing – Easy to follow routine

  • Supports metabolic health – Helps manage obesity-related conditions

  •  

Who are the candidates?

  • BMI ≥30 (classified as obese)

  • BMI ≥27 with at least one weight-related condition, such as:

    • Type 2 diabetes

    • Hypertension

    • High cholesterol

    • Sleep apnea

FAQ

What is Zepbound used for?

Zepbound is used for chronic weight management in adults with obesity or overweight and at least one related health condition.

Zepbound is a once-weekly injection, administered under the skin in the abdomen, thigh, or upper arm.

Weight loss typically begins within a few weeks, with significant results seen by 12 to 16 weeks.

Nausea, vomiting, diarrhea, and constipation are most common, especially during dose escalation.

No, Zepbound is approved for weight loss only. Mounjaro, which also contains tirzepatide, is used for type 2 diabetes.

Scroll to Top